During a Case-Based Roundtable® event, Virginia F. Borges, MD, MMSc, discussed treatment selection for a patient with ER+, ...

Live updates from Selhurst Park as Man United take on Crystal Palace in Saturday's teatime kick-off in the Premier League.

City law firms have been urged to monitor the sleeping patterns of employees suspected of struggling with their mental health ...

Google's Pixel 8  may not be the newest Pixel phone in the franchise anymore, but this deal is too good to pass up if you're ...

Now, to round out the Galaxy S25 series, here's your first look at the Galaxy S25 Plus! Contrary to earlier reports, the ...

Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The ...

NFL Sundays are back! Check out the full slate of games today including tonight's LA Rams vs Detroit Lions thriller on NBC ...

September 16, 2024--Updated results from the HIMALAYA Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) plus IMJUDO® ...

ELVN-002 is being evaluated in combination with trastuzumab plus chemotherapy or as monotherapy in HER2-driven ... ELVN-002 ...

Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...

Announced U.S. FDA authorization of an Expanded Access Policy (EAP) for metastatic breast cancer (MBC) patients. BriaCell Therapeutics Corp. shares T.BCT are trading up $0.05 at $0.70.